Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Perspectives Regarding Hospice Services and Transfusion Access: Focus Groups with Blood Cancer Patients and Bereaved Caregivers.

Henckel C, Revette A, Huntington SF, Tulsky JA, Abel GA, Odejide OO.

J Pain Symptom Manage. 2020 Jan 9. pii: S0885-3924(20)30001-4. doi: 10.1016/j.jpainsymman.2019.12.373. [Epub ahead of print]

PMID:
31926969
2.

Hypomethylating agent (HMA) therapy use and survival in older adults with Refractory Anemia with Excess Blasts (RAEB) in the United States (USA): a large propensity score-matched population-based study.

Davidoff AJ, Hu X, Bewersdorf JP, Wang R, Podoltsev NA, Huntington SF, Gore SD, Ma X, Zeidan AM.

Leuk Lymphoma. 2019 Dec 26:1-10. doi: 10.1080/10428194.2019.1703970. [Epub ahead of print]

PMID:
31878809
3.

Nightly sleep duration, fragmentation, and quality and daily risk of migraine.

Bertisch SM, Li W, Buettner C, Mostofsky E, Rueschman M, Kaplan ER, Fung J, Huntington S, Murphy T, Stead C, Burstein R, Redline S, Mittleman MA.

Neurology. 2020 Feb 4;94(5):e489-e496. doi: 10.1212/WNL.0000000000008740. Epub 2019 Dec 16.

PMID:
31843807
4.

Cure at what (systemic) financial cost? Integrating novel therapies into first-line Hodgkin lymphoma treatment.

Huntington SF.

Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):252-259. doi: 10.1182/hematology.2019000030.

PMID:
31808838
5.

Precision Medicine in Oncology II: Economics of Targeted Agents and Immuno-Oncology Drugs.

Huntington SF, Davidoff AJ, Gross CP.

J Clin Oncol. 2020 Feb 1;38(4):351-358. doi: 10.1200/JCO.19.01573. Epub 2019 Dec 5. No abstract available.

PMID:
31804866
6.

Physician Experience and Risk of Rituximab Discontinuation in Older Adults With Non-Hodgkin's Lymphoma.

Huntington SF, Hoag JR, Wang R, Zeidan AM, Giri S, Gore SD, Ma X, Gross CP, Davidoff AJ.

J Natl Compr Canc Netw. 2019 Oct 1;17(10):1194-1202. doi: 10.6004/jnccn.2019.7314.

PMID:
31590152
7.

Association of provider experience and clinical outcomes in patients with myelodysplastic syndromes receiving hypomethylating agents.

Zeidan AM, Hu X, Zhu W, Stahl M, Wang R, Huntington SF, Giri S, Bewersdorf JP, Podoltsev NA, Gore SD, Ma X, Davidoff AJ.

Leuk Lymphoma. 2020 Feb;61(2):397-408. doi: 10.1080/10428194.2019.1663423. Epub 2019 Oct 1.

PMID:
31570040
8.

Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysis.

Zeidan AM, Podoltsev NA, Wang X, Bewersdorf JP, Shallis RM, Huntington SF, Gore SD, Davidoff AJ, Ma X, Wang R.

Cancer. 2019 Dec 1;125(23):4241-4251. doi: 10.1002/cncr.32439. Epub 2019 Sep 4.

PMID:
31483484
9.

Underutilization of guideline-recommended supportive care among older adults with multiple myeloma in the United States.

Giri S, Zhu W, Wang R, Zeidan A, Podoltsev N, Gore SD, Neparidze N, Ma X, Gross CP, Davidoff AJ, Huntington SF.

Cancer. 2019 Nov 15;125(22):4084-4095. doi: 10.1002/cncr.32428. Epub 2019 Aug 5.

PMID:
31381151
10.

Association Between Ownership of Imaging Equipment and Appropriateness of Staging Positron-Emission Tomography in Non-Hodgkin Lymphoma.

Huntington SF, Zhu W, Hoag JR, Wang R, Zeidan AM, Giri S, Podoltsev NA, Gore SD, Ma X, Gross CP, Davidoff AJ.

JNCI Cancer Spectr. 2019 May 11;3(2):pkz030. doi: 10.1093/jncics/pkz030. eCollection 2019 Jun.

11.

RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis.

Zeidan AM, Zhu W, Stahl M, Wang R, Huntington SF, Giri S, Podoltsev NA, Gore SD, Ma X, Davidoff AJ.

Leuk Lymphoma. 2019 Dec;60(13):3181-3187. doi: 10.1080/10428194.2019.1622700. Epub 2019 Jun 7.

PMID:
31170846
12.

Healthcare expenses for treatment of acute myeloid leukemia.

Bewersdorf JP, Shallis RM, Wang R, Huntington SF, Perreault S, Ma X, Zeidan AM.

Expert Rev Hematol. 2019 Aug;12(8):641-650. doi: 10.1080/17474086.2019.1627869. Epub 2019 Jun 13.

PMID:
31159602
13.

Changes to Model Assumptions of the Cost-effectiveness of Durvalumab Therapy for Non-Small Cell Lung Cancer.

Giri S, Huntington SF.

JAMA Oncol. 2019 Jul 1;5(7):1066. doi: 10.1001/jamaoncol.2019.1088. No abstract available.

PMID:
31095252
14.

Impact of Hydroxyurea on Survival and Risk of Thrombosis Among Older Patients With Essential Thrombocythemia.

Podoltsev NA, Zhu M, Zeidan AM, Wang R, Wang X, Davidoff AJ, Huntington SF, Giri S, Gore SD, Ma X.

J Natl Compr Canc Netw. 2019 Mar 1;17(3):211-219. doi: 10.6004/jnccn.2018.7095.

PMID:
30865915
15.

Reply to H.J.A. Adams et al.

Huntington SF, von Keudell G, Davidoff AJ, Gross CP, Prasad SA.

J Clin Oncol. 2019 Apr 1;37(10):853-854. doi: 10.1200/JCO.18.02297. Epub 2019 Feb 11. No abstract available.

PMID:
30742563
16.

Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis.

Bair SM, Strelec LE, Feldman TA, Ahmed G, Armand P, Shah NN, Singavi AN, Reddy N, Khan N, Andreadis C, Vu K, Huntington SF, Giri S, Ujjani C, Howlett C, Faheem M, Youngman MR, Nasta SD, Landsburg DJ, Schuster SJ, Svoboda J.

Oncologist. 2019 Jul;24(7):955-962. doi: 10.1634/theoncologist.2018-0538. Epub 2018 Dec 19.

17.

The migraine eye: distinct rod-driven retinal pathways' response to dim light challenges the visual cortex hyperexcitability theory.

Bernstein CA, Nir RR, Noseda R, Fulton AB, Huntington S, Lee AJ, Bertisch SM, Hovaguimian A, Buettner C, Borsook D, Burstein R.

Pain. 2019 Mar;160(3):569-578. doi: 10.1097/j.pain.0000000000001434.

PMID:
30376534
18.

The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera.

Podoltsev NA, Zhu M, Zeidan AM, Wang R, Wang X, Davidoff AJ, Huntington SF, Giri S, Gore SD, Ma X.

Blood Adv. 2018 Oct 23;2(20):2681-2690. doi: 10.1182/bloodadvances.2018021436.

19.

Cost-Effectiveness Analysis of Brentuximab Vedotin With Chemotherapy in Newly Diagnosed Stage III and IV Hodgkin Lymphoma.

Huntington SF, von Keudell G, Davidoff AJ, Gross CP, Prasad SA.

J Clin Oncol. 2018 Oct 4:JCO1800122. doi: 10.1200/JCO.18.00122. [Epub ahead of print]

20.

Oncologist volume and outcomes in older adults diagnosed with diffuse large B cell lymphoma.

Huntington SF, Hoag JR, Zhu W, Wang R, Zeidan AM, Giri S, Podoltsev NA, Gore SD, Ma X, Gross CP, Davidoff AJ.

Cancer. 2018 Nov 1;124(21):4211-4220. doi: 10.1002/cncr.31688. Epub 2018 Sep 14.

21.

Modelling-based evaluation of the costs, benefits and cost-effectiveness of multipathogen point-of-care tests for sexually transmitted infections in symptomatic genitourinary medicine clinic attendees.

Huntington SE, Burns RM, Harding-Esch E, Harvey MJ, Hill-Tout R, Fuller SS, Adams EJ, Sadiq ST.

BMJ Open. 2018 Sep 10;8(9):e020394. doi: 10.1136/bmjopen-2017-020394.

22.

Costs of relapsed diffuse large B-cell lymphoma among Medicare patients.

Huntington S, Keshishian A, McGuire M, Xie L, Baser O.

Leuk Lymphoma. 2018 Dec;59(12):2880-2887. doi: 10.1080/10428194.2018.1459613. Epub 2018 Jun 25.

PMID:
29936866
23.

Color-selective photophobia in ictal vs interictal migraineurs and in healthy controls.

Nir RR, Lee AJ, Huntington S, Noseda R, Bernstein CA, Fulton AB, Bertisch SM, Hovaguimian A, Buettner C, Borsook D, Burstein R.

Pain. 2018 Oct;159(10):2030-2034. doi: 10.1097/j.pain.0000000000001303.

24.

Counseling patients with higher-risk MDS regarding survival with azacitidine therapy: are we using realistic estimates?

Zeidan AM, Stahl M, DeVeaux M, Giri S, Huntington S, Podoltsev N, Wang R, Ma X, Davidoff AJ, Gore SD.

Blood Cancer J. 2018 Jun 11;8(6):55. doi: 10.1038/s41408-018-0081-8. No abstract available.

25.

Exposures to Single-Use Detergent Sacs Reported to a Statewide Poison Control System, 2013-2015.

Vohra R, Huntington S, Fenik Y, Phan D, Ta N, Geller RJ.

Pediatr Emerg Care. 2018 May 2. doi: 10.1097/PEC.0000000000001490. [Epub ahead of print]

PMID:
29757892
26.

Real-world treatment and outcomes among older adults with chronic lymphocytic leukemia before the novel agents era.

Mato A, Jahnke J, Li P, Mehra M, Ladage VP, Mahler M, Huntington S, Doshi JA.

Haematologica. 2018 Oct;103(10):e462-e465. doi: 10.3324/haematol.2017.185868. Epub 2018 Apr 26. No abstract available.

27.

The changing face of adult posttransplant lymphoproliferative disorder: Changes in histology between 1999 and 2013.

Tsai DE, Bagley S, Reshef R, Shaked A, Bloom RD, Ahya V, Goldberg L, Chung A, Debonera F, Schuster SJ, Huntington SF.

Am J Hematol. 2018 Jul;93(7):874-881. doi: 10.1002/ajh.25116. Epub 2018 May 6.

28.

R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis.

Shah NN, Szabo A, Huntington SF, Epperla N, Reddy N, Ganguly S, Vose J, Obiozor C, Faruqi F, Kovach AE, Costa LJ, Xavier AC, Okal R, Kanate AS, Ghosh N, Kharfan-Dabaja MA, Strelec L, Hamadani M, Fenske TS, Calzada O, Cohen JB, Chavez J, Svoboda J.

Br J Haematol. 2018 Feb;180(4):534-544. doi: 10.1111/bjh.15051. Epub 2017 Dec 19. Erratum in: Br J Haematol. 2018 Apr;181(1):152.

PMID:
29265182
29.

Long-term survival of older patients with MDS treated with HMA therapy without subsequent stem cell transplantation.

Zeidan AM, Stahl M, Hu X, Wang R, Huntington SF, Podoltsev NA, Gore SD, Ma X, Davidoff AJ.

Blood. 2018 Feb 15;131(7):818-821. doi: 10.1182/blood-2017-10-811729. Epub 2017 Dec 19. No abstract available.

30.

Heady Mystery: Intoxicated patient's misplaced memory hides undiscovered trauma.

Huntington SA, Huntington MK.

JEMS. 2016 Oct;41(10):16-9. No abstract available.

PMID:
29185681
31.

Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study.

Zeidan AM, Long JB, Wang R, Hu X, Yu JB, Huntington SF, Abel GA, Mougalian SS, Podoltsev NA, Gore SD, Gross CP, Ma X, Davidoff AJ.

PLoS One. 2017 Sep 13;12(9):e0184747. doi: 10.1371/journal.pone.0184747. eCollection 2017.

32.

Pediatric Exposures to Topical Benzocaine Preparations Reported to a Statewide Poison Control System.

Vohra R, Huntington S, Koike J, Le K, Geller RJ.

West J Emerg Med. 2017 Aug;18(5):923-927. doi: 10.5811/westjem.2017.6.33665. Epub 2017 Jul 14.

33.

Health Care Use by Older Adults With Acute Myeloid Leukemia at the End of Life.

Wang R, Zeidan AM, Halene S, Xu X, Davidoff AJ, Huntington SF, Podoltsev NA, Gross CP, Gore SD, Ma X.

J Clin Oncol. 2017 Oct 20;35(30):3417-3424. doi: 10.1200/JCO.2017.72.7149. Epub 2017 Aug 7.

34.

Cost-effectiveness analysis of consolidation with brentuximab vedotin for high-risk Hodgkin lymphoma after autologous stem cell transplantation.

Hui L, von Keudell G, Wang R, Zeidan AM, Gore SD, Ma X, Davidoff AJ, Huntington SF.

Cancer. 2017 Oct 1;123(19):3763-3771. doi: 10.1002/cncr.30818. Epub 2017 Jun 22.

35.

Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based study.

Zeidan AM, Hu X, Long JB, Wang R, Ma X, Podoltsev NA, Huntington SF, Gore SD, Davidoff AJ.

Cancer. 2017 Oct 1;123(19):3754-3762. doi: 10.1002/cncr.30814. Epub 2017 Jun 16.

36.

Filling out the forms: Health literacy among the uninsured.

Lane SD, Huntington SJ, Satterly LB Md, Rubinstein RA, Keefe RH, Project Student Researchers A Brian Buckley Caitlin Cornell Alyssa Fuller Eric Hojnowski Ryan LaFollette Yelena Livshits Todd Michaelis Claire Motyl Tarakad Ramachandran Devan Rahmachandrin Sofia Seckler Evaline Tso And Kate Zmijewski-Mekeem.

Soc Work Health Care. 2017 Sep;56(8):686-699. doi: 10.1080/00981389.2017.1331947. Epub 2017 Jun 12.

PMID:
28605296
37.

High-Cost, High-Value Oral Specialty Drugs: More Evidence on the Impact of Cost Sharing in Medicare Part D.

Huntington SF, Davidoff AJ.

J Clin Oncol. 2016 Dec 20;34(36):4307-4309. Epub 2016 Nov 14. No abstract available.

PMID:
27998230
38.

Myelodysplastic Syndromes and Acute Myeloid Leukemia After Radiotherapy for Prostate Cancer: A Population-Based Study.

Wang R, Zeidan AM, Yu JB, Soulos PR, Davidoff AJ, Gore SD, Huntington SF, Gross CP, Ma X.

Prostate. 2017 Apr;77(5):437-445. doi: 10.1002/pros.23281. Epub 2016 Nov 21.

39.

Cancer-related financial toxicity: beyond the realm of drug pricing and out-of-pocket costs.

Huntington SF.

Ann Oncol. 2016 Dec;27(12):2143-2145. doi: 10.1093/annonc/mdw540. Epub 2016 Oct 13. No abstract available.

40.

Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes.

Zeidan AM, Davidoff AJ, Long JB, Hu X, Wang R, Ma X, Gross CP, Abel GA, Huntington SF, Podoltsev NA, Hajime U, Prebet T, Gore SD.

Br J Haematol. 2016 Dec;175(5):829-840. doi: 10.1111/bjh.14305. Epub 2016 Sep 21.

PMID:
27650975
41.

Modest improvement in survival of patients with refractory anemia with excess blasts in the hypomethylating agents era in the United States.

Zeidan AM, Wang R, Gross CP, Gore SD, Huntington SF, Prebet T, Abel GA, Davidoff AJ, Ma X.

Leuk Lymphoma. 2017 Apr;58(4):982-985. doi: 10.1080/10428194.2016.1214954. Epub 2016 Aug 25. No abstract available.

PMID:
27558206
42.

High cost sharing and specialty drug initiation under Medicare Part D: a case study in patients with newly diagnosed chronic myeloid leukemia.

Doshi JA, Li P, Huo H, Pettit AR, Kumar R, Weiss BM, Huntington SF.

Am J Manag Care. 2016 Mar;22(4 Suppl):s78-86.

43.

Negative Studies in Cancer Research: Why the Negativity?

Huntington SF, Gross CP.

JAMA Oncol. 2016 Jul 1;2(7):865-6. doi: 10.1001/jamaoncol.2015.6540. No abstract available.

PMID:
26967116
44.

Human bromethalin exposures reported to a U.S. Statewide Poison Control System.

Huntington S, Fenik Y, Vohra R, Geller RJ.

Clin Toxicol (Phila). 2016 Mar;54(3):277-81. doi: 10.3109/15563650.2016.1139713. Epub 2016 Feb 9.

PMID:
26860212
45.

Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.

Huntington SF, Weiss BM, Vogl DT, Cohen AD, Garfall AL, Mangan PA, Doshi JA, Stadtmauer EA.

Lancet Haematol. 2015 Oct;2(10):e408-16. doi: 10.1016/S2352-3026(15)00151-9. Epub 2015 Sep 17.

PMID:
26686042
46.

The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy.

Huntington S, Thorne C, Newell ML, Anderson J, Taylor GP, Pillay D, Hill T, Tookey PA, Sabin C; UK Collaborative HIV Cohort (UK CHIC) Study and the UK and Ireland National Study of HIV in Pregnancy and Childhood (NSHPC).

AIDS. 2015 Nov;29(17):2269-78. doi: 10.1097/QAD.0000000000000826.

47.

Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells.

Evans AG, Rothberg PG, Burack WR, Huntington SF, Porter DL, Friedberg JW, Liesveld JL.

Br J Haematol. 2015 Oct;171(2):205-209. doi: 10.1111/bjh.13562. Epub 2015 Jun 18.

PMID:
26084925
48.

Cost-effectiveness analysis of routine surveillance imaging of patients with diffuse large B-cell lymphoma in first remission.

Huntington SF, Svoboda J, Doshi JA.

J Clin Oncol. 2015 May 1;33(13):1467-74. doi: 10.1200/JCO.2014.58.5729. Epub 2015 Mar 30.

PMID:
25823735
49.

Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy.

Huntington S, Thorne C, Newell ML, Anderson J, Taylor GP, Pillay D, Hill T, Tookey PA, Sabin C; UK Collaborative HIV Cohort (UK CHIC) Study; UK and Ireland National Study of HIV in Pregnancy and Childhood (NSHPC).

AIDS. 2015 Apr 24;29(7):801-9. doi: 10.1097/QAD.0000000000000620.

50.

Utility of interim and end-of-treatment [(18)F]-fluorodeoxyglucose positron emission tomography-computed tomography in frontline therapy of patients with diffuse large B-cell lymphoma.

Huntington SF, Nasta SD, Schuster SJ, Doshi JA, Svoboda J.

Leuk Lymphoma. 2015;56(9):2579-84. doi: 10.3109/10428194.2015.1007506. Epub 2015 Feb 11.

PMID:
25629993

Supplemental Content

Loading ...
Support Center